Grand Pharmaceutical Group Limited (HKG:0512)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.37
+0.04 (0.63%)
Apr 29, 2026, 9:33 AM HKT
8.70%
Market Cap 22.17B
Revenue (ttm) 12.28B
Net Income (ttm) 1.24B
Shares Out 3.50B
EPS (ttm) 0.35
PE Ratio 17.86
Forward PE 13.19
Dividend 0.17 (2.67%)
Ex-Dividend Date Jun 12, 2026
Volume 100,500
Average Volume 6,081,449
Open 6.36
Previous Close 6.33
Day's Range 6.33 - 6.37
52-Week Range 5.77 - 10.20
Beta 0.85
RSI 35.25
Earnings Date May 19, 2026

About HKG:0512

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additive... [Read more]

Sector Healthcare
Founded 1995
Employees 12,614
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0512
Full Company Profile

Financial Performance

In 2025, HKG:0512's revenue was 12.28 billion, an increase of 5.48% compared to the previous year's 11.64 billion. Earnings were 1.24 billion, a decrease of -49.73%.

Financial Statements

News

There is no news available yet.